Medicine & pharma · Official intelligence
Once-Weekly Ribupatide for Weight Loss in Adults in China With Overweight or Obesity: The GEMINI-1 Randomized Clinical Trial
A randomized clinical trial published in JAMA evaluated the efficacy of once-weekly ribupatide for weight loss in Chinese adults with overweight or obesity. This study provides new evidence on the effectiveness of this treatment regimen for managing obesity in this population.
Original source
Read the source — pubmed.ncbi.nlm.nih.gov ↗We link to the original publisher. The summary above is a short guide; read the original for the full details.